GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BICO Group AB (OTCPK:BCCOY) » Definitions » EV-to-EBITDA

BCCOY (BICO Group AB) EV-to-EBITDA : 21.03 (As of May. 27, 2025)


View and export this data going back to 2021. Start your Free Trial

What is BICO Group AB EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BICO Group AB's enterprise value is $313.0 Mil. BICO Group AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was $14.9 Mil. Therefore, BICO Group AB's EV-to-EBITDA for today is 21.03.

The historical rank and industry rank for BICO Group AB's EV-to-EBITDA or its related term are showing as below:

BCCOY' s EV-to-EBITDA Range Over the Past 10 Years
Min: -2717.08   Med: 13.84   Max: 7787.22
Current: 19.91

During the past 9 years, the highest EV-to-EBITDA of BICO Group AB was 7787.22. The lowest was -2717.08. And the median was 13.84.

BCCOY's EV-to-EBITDA is ranked worse than
62.58% of 497 companies
in the Medical Devices & Instruments industry
Industry Median: 15.16 vs BCCOY: 19.91

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-27), BICO Group AB's stock price is $0.80. BICO Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was $-0.085. Therefore, BICO Group AB's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


BICO Group AB EV-to-EBITDA Historical Data

The historical data trend for BICO Group AB's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BICO Group AB EV-to-EBITDA Chart

BICO Group AB Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only -173.50 462.08 8.39 11.74 6.82

BICO Group AB Quarterly Data
Feb20 May20 Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.75 -20.42 -17.46 6.82 17.47

Competitive Comparison of BICO Group AB's EV-to-EBITDA

For the Medical Devices subindustry, BICO Group AB's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BICO Group AB's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BICO Group AB's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BICO Group AB's EV-to-EBITDA falls into.


;
;

BICO Group AB EV-to-EBITDA Calculation

BICO Group AB's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=313.020/14.887
=21.03

BICO Group AB's current Enterprise Value is $313.0 Mil.
BICO Group AB's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $14.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BICO Group AB  (OTCPK:BCCOY) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

BICO Group AB's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.80/-0.085
=At Loss

BICO Group AB's share price for today is $0.80.
BICO Group AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.085.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


BICO Group AB EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of BICO Group AB's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


BICO Group AB Business Description

Traded in Other Exchanges
Address
Langfilsgatan 9, Gothenburg, SWE, 41277
BICO Group AB is a bio-convergence company. The company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Group consists of three reporting segments: Bioprinting, Life Science Solutions, and Lab Automation. Bioprinting consists of CELLINK, MatTek, Visikol, and Advanced BioMatrix. Life Science Solutions consists of CYTENA, DISPENDIX, Discover Echo, QInstruments, SCIENION, and Cellenion. Lab Automation consists of Biosero.